aconitic anhydride has been researched along with aconitic acid in 14 studies
*Aconitic Acid: A tricarboxylic acid with the formula (COOH)-CH2-C(COOH)=CH-COOH. [MeSH]
*Aconitic Acid: A tricarboxylic acid with the formula (COOH)-CH2-C(COOH)=CH-COOH. [MeSH]
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (14.29) | 18.7374 |
1990's | 2 (14.29) | 18.2507 |
2000's | 1 (7.14) | 29.6817 |
2010's | 9 (64.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
De Béthune, MP; De Clercq, E; Kamps, JA; Meijer, DK; Morselt, HW; Pauwels, R; Scherphof, GL; Swart, PJ | 1 |
Ertl, B; Fuchs, A; Gabor, F; Wirth, M; Wolf, M | 1 |
FELDMANN, EG; KOEHLER, HM | 1 |
PALUMBO, M; SACCA, S | 1 |
Martynov, AV; Smelyanskaya, MV | 1 |
Che, CT; Chen, JY; Duan, JA; Goedecke, T; Xu, LJ; Zhang, XQ; Zhao, M | 1 |
Alberti, K; Arellano, CL; Sun, S; Wang, M; Xu, Q | 1 |
Chen, J; Chen, X; Ding, J; Sun, D; Xiao, C; Zhuang, X | 1 |
Battogtokh, G; Ko, YT | 1 |
Jia, Y; Liu, S; Liu, X; Pan, W; Tian, C; Wang, H; Wang, Y; Yan, J | 1 |
Guo, YZ; Liang, JM; Ling, CL; Liu, JX; Pang, L; Qin, J; Wang, BS; Wang, JX; Wang, Q; Zhang, C | 1 |
Cheng, DB; Cong, Y; Gao, YJ; Hu, Z; Ji, L; Liu, FH; Qiao, ZY; Wang, H | 1 |
Chen, X; Wei, W; Xu, X; Zhang, X; Zhou, M | 1 |
Chen, YF; Chen, ZJ; Li, Y; Liu, YB; Tan, QG; Wang, XF; Wu, WG; Xu, XY | 1 |
14 other study(ies) available for aconitic anhydride and aconitic acid
Article | Year |
---|---|
Preparation and characterization of conjugates of (modified) human serum albumin and liposomes: drug carriers with an intrinsic anti-HIV activity.
Topics: Aconitic Acid; Anions; Antiviral Agents; Drug Carriers; HIV-1; Humans; Kinetics; Liposomes; Liver; Phosphatidylethanolamines; Polyethylene Glycols; Serum Albumin; Tissue Distribution | 1996 |
Lectin-mediated drug targeting: preparation, binding characteristics, and antiproliferative activity of wheat germ agglutinin conjugated doxorubicin on Caco-2 cells.
Topics: Aconitic Acid; Antibiotics, Antineoplastic; Caco-2 Cells; Cell Division; Cells, Cultured; Chemistry, Pharmaceutical; Colon; Doxorubicin; Drug Carriers; Drug Delivery Systems; Flow Cytometry; Humans; Lymphocytes; Wheat Germ Agglutinins | 1998 |
The colorimetric determination of lidocaine with cis-aconitic anhydride.
Topics: Aconitic Acid; Colorimetry; Humans; Lidocaine | 1959 |
[Colorimetric determination of alkaloids using cis-aconitic anhydride].
Topics: Aconitic Acid; Alkaloids; Colorimetry; Indicators and Reagents | 1962 |
Antiproliferative properties of chemically modified recombinant IFN-alpha2b.
Topics: Aconitic Acid; Acylation; Antineoplastic Agents; Cell Line, Tumor; Growth Inhibitors; Humans; Interferon alpha-2; Interferon-alpha; Recombinant Proteins; Succinic Anhydrides | 2005 |
Cis-aconitic anhydride ethyl ester and phenolic compounds from the seeds of Alisma orientale.
Topics: Aconitic Acid; Alisma; Cyclohexanones; Glucosides; Norisoprenoids; Phenols; Seeds | 2012 |
Combinatorially designed lipid-like nanoparticles for intracellular delivery of cytotoxic protein for cancer therapy.
Topics: Aconitic Acid; Alkanes; Amines; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Humans; Lipids; Mice; Nanoparticles; Neoplasms; Ribonuclease, Pancreatic; Ribosome Inactivating Proteins, Type 1; Saporins | 2014 |
Preclinical evaluation of antitumor activity of acid-sensitive PEGylated doxorubicin.
Topics: Acids; Aconitic Acid; Cell Line, Tumor; Doxorubicin; Drug Delivery Systems; Humans; Hydrogen-Ion Concentration; Micelles; Neoplasms; Particle Size; Polyethylene Glycols | 2014 |
Graphene oxide-incorporated pH-responsive folate-albumin-photosensitizer nanocomplex as image-guided dual therapeutics.
Topics: Aconitic Acid; Animals; Chlorophyll; Drug Liberation; Folic Acid; Graphite; Humans; Lasers; MCF-7 Cells; Melanoma, Experimental; Mice; Mice, Nude; Microscopy, Confocal; Nanoconjugates; Oxides; Photochemotherapy; Photosensitizing Agents; Serum Albumin, Bovine; Xenograft Model Antitumor Assays | 2016 |
Co-delivery of docetaxel and curcumin prodrug via dual-targeted nanoparticles with synergistic antitumor activity against prostate cancer.
Topics: Aconitic Acid; Animals; Antineoplastic Agents; Cell Death; Cell Line, Tumor; Coumarins; Curcumin; Docetaxel; Drug Delivery Systems; Drug Liberation; Drug Stability; Drug Synergism; Endocytosis; Humans; Inhibitory Concentration 50; Lactic Acid; Male; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Particle Size; Peptides; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Prodrugs; Prostatic Neoplasms; Proton Magnetic Resonance Spectroscopy; Taxoids; Thiazoles | 2017 |
Direct Macromolecular Drug Delivery to Cerebral Ischemia Area using Neutrophil-Mediated Nanoparticles.
Topics: Aconitic Acid; Animals; Brain; Brain Ischemia; Catalase; Cell Communication; Cell Death; Cell Differentiation; Dendrimers; Drug Delivery Systems; Endocytosis; Exosomes; HL-60 Cells; Humans; Infarction, Middle Cerebral Artery; Macromolecular Substances; Male; Mice, Inbred C57BL; Mice, Nude; Nanoparticles; Neutrophils; Peptides; Polymers; Proton Magnetic Resonance Spectroscopy; Reperfusion Injury; Treatment Outcome | 2017 |
Microenvironment-Induced In Situ Self-Assembly of Polymer-Peptide Conjugates That Attack Solid Tumors Deeply.
Topics: Aconitic Acid; Administration, Intravenous; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Delivery Systems; Drug Screening Assays, Antitumor; Humans; Hydrogen-Ion Concentration; Mice; Particle Size; Peptides; Polymers; Surface Properties; Tumor Microenvironment | 2019 |
pH and redox dual responsive carrier-free anticancer drug nanoparticles for targeted delivery and synergistic therapy.
Topics: Aconitic Acid; Animals; Antineoplastic Agents; Cell Line, Tumor; Cross-Linking Reagents; Drug Carriers; Drug Delivery Systems; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Endocytosis; Humans; Hyaluronic Acid; Hydrogen-Ion Concentration; Mice, Inbred BALB C; Nanoparticles; Oxidation-Reduction; Paclitaxel | 2019 |
Construction of multilayer films with bactericidal and long-term antitumor drug release properties as a non-vascular stent coating for therapy in obstruction.
Topics: Aconitic Acid; Alginates; Anti-Bacterial Agents; Antineoplastic Agents; Doxorubicin; Drug Carriers; Drug Liberation; Hydrogen-Ion Concentration; Polyethyleneimine; Stents | 2019 |